SAB Biotherapeutics Warrant
SABSW
SABSW
21 hedge funds and large institutions have $3.86M invested in SAB Biotherapeutics Warrant in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
21
Holding in Top 10
–
Calls
$2.34M
Puts
–
Top Buyers
| 1 | +$819K | |
| 2 | +$127K | |
| 3 | +$66K | |
| 4 |
Morgan Stanley
New York
|
+$56K |
| 5 |
CCM
Context Capital Management
Lajolla,
California
|
+$36.7K |
Top Sellers
| 1 | -$726K | |
| 2 | -$242K | |
| 3 | -$208K | |
| 4 |
KC
Kepos Capital
New York
|
-$183K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$161K |